These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38089873)

  • 1. Development of an autoantibody panel for early detection of lung cancer in the Chinese population.
    Tong L; Sun J; Zhang X; Ge D; Li Y; Zhou J; Wang D; Hu X; Liu H; Bai C
    Front Med (Lausanne); 2023; 10():1209747. PubMed ID: 38089873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.
    Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z
    Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.
    Chapman CJ; Healey GF; Murray A; Boyle P; Robertson C; Peek LJ; Allen J; Thorpe AJ; Hamilton-Fairley G; Parsy-Kowalska CB; MacDonald IK; Jewell W; Maddison P; Robertson JF
    Tumour Biol; 2012 Oct; 33(5):1319-26. PubMed ID: 22492236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
    PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of lung cancer by using an autoantibody panel in Chinese population.
    Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
    Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody Signatures as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Shi QP; Wang X; Liu ZX; Zhang JJ; Wang ZY
    Arch Med Res; 2021 Aug; 52(6):620-626. PubMed ID: 33653596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.
    Cui X; Heuvelmans MA; Han D; Zhao Y; Fan S; Zheng S; Sidorenkov G; Groen HJM; Dorrius MD; Oudkerk M; de Bock GH; Vliegenthart R; Ye Z
    Transl Lung Cancer Res; 2019 Oct; 8(5):605-613. PubMed ID: 31737497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer.
    Healey GF; Lam S; Boyle P; Hamilton-Fairley G; Peek LJ; Robertson JF
    J Thorac Dis; 2013 Oct; 5(5):618-25. PubMed ID: 24255775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
    Li W; Sun Y; Xu N
    Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
    Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
    [No Abstract]   [Full Text] [Related]  

  • 14. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
    Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH
    J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with 'Actionable' Pulmonary Nodules.
    Auger C; Moudgalya H; Neely MR; Stephan JT; Tarhoni I; Gerard D; Basu S; Fhied CL; Abdelkader A; Vargas M; Hu S; Hulett T; Liptay MJ; Shah P; Seder CW; Borgia JA
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features.
    Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J
    Front Oncol; 2022; 12():883543. PubMed ID: 35530343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of an autoantibody test for lung cancer.
    Boyle P; Chapman CJ; Holdenrieder S; Murray A; Robertson C; Wood WC; Maddison P; Healey G; Fairley GH; Barnes AC; Robertson JF
    Ann Oncol; 2011 Feb; 22(2):383-9. PubMed ID: 20675559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
    Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
    BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
    Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
    Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.